Norbaeocystin

Norbaeocystin
Clinical data
Other names	4-Phosphoryloxytryptamine; 4-PO-T; 4-Hydroxytryptamine 4-phosphate; 4-Hydroxytryptamine phosphate
Routes of; administration	Oral
Drug class	Serotonin receptor agonist; Non-hallucinogenic serotonin 5-HT2A receptor agonist
ATC code	None;
Legal status
Legal status	US: Schedule I by analogue;
Identifiers
	IUPAC name 3-(2-ammonioethyl)-1H-indol-4-yl hydrogen phosphate;
CAS Number	21420-59-7;
PubChem CID	9795063;
ChemSpider	7970830;
UNII	C8CA0W9FJ9;
KEGG	C21778;
ChEBI	CHEBI:139479 ;
CompTox Dashboard (EPA)	DTXSID601193769 ;
Chemical and physical data
Formula	C10H13N2O4P
Molar mass	256.198 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES NCCc1c[nH]c2cccc(OP(=O)(O)O)c12;
	InChI InChI=1S/C10H13N2O4P/c11-5-4-7-6-12-8-2-1-3-9(10(7)8)16-17(13,14)15/h1-3,6,12H,4-5,11H2,(H2,13,14,15); Key:IKQGYCWFBVEAKF-UHFFFAOYSA-N;
	(verify)

Norbaeocystin, also known as 4-phosphoryloxytryptamine (4-PO-T), is a psilocybin mushroom alkaloid of the tryptamine family and an analogue of psilocybin (4-PO-DMT). It is found as a minor compound in most psilocybin mushrooms, together with psilocybin, psilocin (4-HO-DMT), aeruginascin (4-PO-TMT), and baeocystin (4-PO-NMT), from which it is a derivative.